[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100626467":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":24,"centralContacts":28,"locations":34,"responsibleParty":51,"collaborators":24,"id":55,"slug":56,"hasResults":57,"nctId":58,"briefTitle":59,"officialTitle":60,"acronym":24,"eligibilityCriteria":61,"healthyVolunteers":57,"sex":62,"minAge":63,"maxAge":64,"enrollmentInfo":65,"targetDuration":24,"studyType":68,"phases":69,"briefSummary":71,"conditions":72,"keywords":74,"overallStatus":37,"whyStopped":24,"lastUpdateSubmitDate":82,"lastUpdatePostDateStruct":83,"startDateStruct":86,"completionDateStruct":88,"leadSponsor":90,"locationsCount":91},{"fullName":5,"class":6},"General Committee of Teaching Hospitals and Institutes, Egypt","OTHER_GOV",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Group non banded","ACTIVE_COMPARATOR","Standard revisional RYGB",[13],"Procedure: Standard revisional RYGB",{"label":15,"type":10,"description":16,"interventionNames":17},"Group banded","Revisional Banded RYGB",[18],"Procedure: Revisional Banded RYGB",[20,25],{"type":21,"name":11,"description":22,"armGroupLabels":23,"otherNames":24},"PROCEDURE","* Small gastric pouch (\\~30 mL).\n* 100-150 cm alimentary limb, 50 cm biliopancreatic limb.",[9],null,{"type":21,"name":16,"description":26,"armGroupLabels":27,"otherNames":24},"* Standard RYGB as above.\n* Placement of a silastic ring (5.5-7.0 cm circumference) around the gastric pouch, \\~2 cm above the gastrojejunal anastomosis.",[15],[29],{"name":30,"role":31,"phone":32,"phoneExt":24,"email":33},"Mohamed H Ashour, PhD","CONTACT","00201002600970","dr.mhany@gmail.com",[35],{"facility":36,"status":37,"city":38,"state":39,"zip":40,"country":41,"countryCode":42,"cosmosGeoPoint":43,"geoPoint":48,"contacts":49},"The surgical department of Medical Research Institute Hospital, Alexandria University","RECRUITING","Alexandria","Alexandria Governorate","21531","Egypt","EG",{"type":44,"coordinates":45},"Point",[46,47],29.91582,31.20176,{"lat":47,"lon":46},[50],{"name":30,"role":31,"phone":32,"phoneExt":24,"email":33},{"type":52,"investigatorFullName":53,"investigatorTitle":54,"investigatorAffiliation":5,"oldNameTitle":24,"oldOrganization":24},"PRINCIPAL_INVESTIGATOR","Mohamed Hany Ashour","Professor of General surgery","100626467","comparing-revisional-laparoscopic-roux-en-y-gastric-bypass-versus-ringed-revisional-roux-en-y-gastric-bypass-after-laparoscopic-sleeve-gastrectomy-100626467",false,"NCT07436013","Comparing Revisional Laparoscopic Roux-en-Y Gastric Bypass Versus Ringed Revisional Roux-en-Y Gastric Bypass After Laparoscopic Sleeve Gastrectomy","A Prospective Randomized Controlled Trial Comparing Revisional Laparoscopic Roux-en-Y Gastric Bypass Versus Ringed Revisional Roux-en-Y Gastric Bypass After Laparoscopic Sleeve Gastrectomy: 5-Year Outcomes on Weight Loss, BAROS Score, Quality of Life, and Food Tolerance","Inclusion Criteria:\n\n* Adults aged 18-65 years.\n* Patients who experienced recurrent weight gain, suboptimal weight loss, or both within 12-24 months or more following sleeve gastrectomy.\n* Eligible and fit for bariatric surgery.\n* Willing to provide informed consent and adhere to follow-up.\n\nExclusion Criteria:\n\n* Severe psychiatric disorders or uncontrolled substance abuse.\n* Pregnancy or planned pregnancy within 2 years post-surgery.\n* Chronic steroid use or immunosuppressive therapy.\n* Active malignancy or history of gastrointestinal cancer.\n* Severe cardiac or pulmonary disease precluding surgery.\n* Uncontrolled endocrine disorders (other than T2DM).\n* Inability to comply with follow-up or protocol requirements.","ALL","18 Years","65 Years",{"count":66,"type":67},240,"ESTIMATED","INTERVENTIONAL",[70],"NA","Obesity remains a major global health challenge, with rising prevalence and significant metabolic, cardiovascular, and gastrointestinal comorbidities. Laparoscopic sleeve gastrectomy (LSG) has emerged as the most widely performed bariatric procedure due to its technical simplicity and satisfactory short- to mid-term results. However, a proportion of patients experience suboptimal weight loss, recurrent weight gain, or both.\n\nIn this study, patients with recurrent weight gain of maximum weight loss or suboptimal weight loss or both following sleeve gastrectomy were included.\n\nSuboptimal weight loss is defined as total weight loss (TWL) of less than 20% of the preoperative weight and\u002For excess weight loss (EWL) of less than 50%, measured at least 12-18 months after the primary sleeve gastrectomy.\n\nRecurrent weight gain after sleeve gastrectomy is defined as an increase of ≥20% of the maximum weight loss (from nadir weight) or an increase in BMI of \\>5, measured at least 24 months after the primary procedure.",[73],"Revisional Bariatric Surgery",[75,76,77,78,79,80,81],"Gastric Bypass","Revisional Laparoscopic Roux-en-Y","Ringed Revisional Roux-en-Y","Weight Loss","BAROS Score","Quality of Life","Food Tolerance","2026-04-24",{"date":84,"type":85},"2026-04-29","ACTUAL",{"date":87,"type":85},"2026-03-15",{"date":89,"type":67},"2031-03",{"name":5,"class":6},1]